Issue link: https://www.e-digitaleditions.com/i/1440975
Inhalation January 2022 13 Catalent Pharma Solutions Cliantha Research Coster Tecnologie Speciali S.p.A. DCA Design International Emmace Consulting AB Freeman Technology (a Micromeritics Co.) Gateway Analytical H&T Presspart Harro Höfliger Verpackungsmachinen HCmed Innovations Co., Ltd. i2c Pharmaceutical Services Inhalation Sciences Intech Biopharm, Ltd. Intertek Kindeva Drug Delivery Material Flow Solutions MVIC AB Next Breath Oz-UK, Ltd. Quotient Sciences Recipharm AB Siemens Team Consulting e Technology Partnership, PLC Xedev Contract testing Aptar Pharma Buchi Corporation Cardiff Scintigraphics O OUTSOURCING SERVICES API development DCA Design International Gateway Analytical Hovione Intertek Lonza Material Flow Solutions Recipharm AB e Technology Partnership, PLC Clinical trials Cardiff Scintigraphics Cliantha Research Harro Hoefliger Packaging Systems, Inc. i2c Pharmaceutical Services Lonza Quotient Sciences CMC Aptar Pharma Catalent Pharma Solutions Lonza Quotient Sciences Recipharm Vectura Contract manufacturing Catalent Pharma Solutions Harro Hoefliger Packaging Systems, Inc. Hovione Kindeva Drug Delivery Lonza Quotient Sciences Recipharm AB Renaissance Vectura Contract research Buchi Corporation Cardiff Scintigraphics Catalent Pharma Solutions Cliantha Research DCA Design International Emmace Consulting AB Gateway Analytical Hovione i2c Pharmaceutical Services Inhalation Sciences Intertek Kindeva Drug Delivery Lonza Lovelace Biomedical Trusted, Reliable Contract Development & Manufacturing renpharm.com R&D Services – Formulation – Scale-up – Stability – 2-100 mL vials – 2-100 mL vials Injectables – Multi-Dose – Unit Dose – Bi-Dose Multi-Dose – Unit Dose – Bi-Dose Nasal Renaissance develops and manufactures high-quality pharmaceuticals to fulfill your patients' needs.